Dr. Sayeeda A. Jabeen, MD

Dr. Jabeen practices at HSHS St. John's Hospital in Springfield, Illinois, part of Hospital Sisters of St. Francis.

Dr. Jabeen's NPI, 1891882601, was assigned on October 5, 2006. Dr. Jabeen holds Illinois license 036-116389.

Dr. Jabeen's primary practice is HSHS St. John's Hospital, at 800 E Carpenter St, Springfield, IL 62769 in Sangamon County. The practice phone is (217) 544-6464.

Dr. Jabeen's primary practice is HSHS St. John's Hospital in Springfield, Illinois, part of Hospital Sisters of St. Francis. Dr. Jabeen is also affiliated with Springfield Memorial Hospital. The medical group on file is SIU Medicine. Dmand AI also links Dr. Jabeen to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jabeen practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Jabeen's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Jabeen is licensed in Illinois.

CMS data shows 1,111 Medicare services from Dr. Jabeen across 6 procedure codes in 2024, for 346 Medicare patients. Medicare paid $105,904 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 346 Medicare patients who saw Dr. Jabeen in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jabeen's median patient age at 68, with 50% women.

In 2024, Dr. Jabeen wrote 541 Medicare Part D claims for 210 patients. 89% of them were for generic drugs. CMS names the drug for 304 of them, across 16 drugs with 11 or more claims each, at $8,626 in total drug cost. In 2023, CMS named 295 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Jabeen for performance year 2024, reported as part of a group. Dr. Jabeen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Jabeen to 1 clinical trial. Conditions studied include COVID-19 and Pneumonia, Viral.

CMS Open Payments shows 17 general payments to Dr. Jabeen from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $136.